204 related articles for article (PubMed ID: 35842443)
1. Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation.
Jiang B; Zhao X; Chen W; Diao W; Ding M; Qin H; Li B; Cao W; Chen W; Fu Y; He K; Gao J; Chen M; Lin T; Deng Y; Yan C; Guo H
Nat Commun; 2022 Jul; 13(1):4141. PubMed ID: 35842443
[TBL] [Abstract][Full Text] [Related]
2. Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination.
Pak Y; Glowacka WK; Bruce MC; Pham N; Rotin D
J Cell Biol; 2006 Nov; 175(4):631-45. PubMed ID: 17116753
[TBL] [Abstract][Full Text] [Related]
3. LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway.
Wang Y; Liu J; Akatsu C; Zhang R; Zhang H; Zhu H; Liu K; Zhu HY; Min Q; Meng X; Cui C; Tang Y; Yu M; Li Y; Feng X; Wei H; Wen Z; Ji S; Weigert MG; Tsubata T; Wang JY
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2205629119. PubMed ID: 36037365
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal-associated protein transmembrane 5 ameliorates non-alcoholic steatohepatitis by promoting the degradation of CDC42 in mice.
Jiang L; Zhao J; Yang Q; Li M; Liu H; Xiao X; Tian S; Hu S; Liu Z; Yang P; Chen M; Ye P; Xia J
Nat Commun; 2023 May; 14(1):2654. PubMed ID: 37156795
[TBL] [Abstract][Full Text] [Related]
5. LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages.
Glowacka WK; Alberts P; Ouchida R; Wang JY; Rotin D
J Biol Chem; 2012 Aug; 287(33):27691-702. PubMed ID: 22733818
[TBL] [Abstract][Full Text] [Related]
6.
Yang X; Wen Y; Liu S; Duan L; Liu T; Tong Z; Wang Z; Gu Y; Xi Y; Wang X; Luo D; Zhang R; Liu Y; Wang Y; Cheng T; Jiang S; Zhu X; Yang X; Pan Y; Cheng S; Ye Q; Chen J; Xu X; Gao S
Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35091468
[TBL] [Abstract][Full Text] [Related]
7. HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.
Ishihara T; Inoue J; Kozaki KI; Imoto I; Inazawa J
J Biol Chem; 2011 Dec; 286(51):44086-44094. PubMed ID: 22009753
[TBL] [Abstract][Full Text] [Related]
8. LAPTM5 promotes lysosomal degradation of intracellular CD3ζ but not of cell surface CD3ζ.
Kawai Y; Ouchida R; Yamasaki S; Dragone L; Tsubata T; Wang JY
Immunol Cell Biol; 2014 Jul; 92(6):527-34. PubMed ID: 24638062
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas.
Inoue J; Misawa A; Tanaka Y; Ichinose S; Sugino Y; Hosoi H; Sugimoto T; Imoto I; Inazawa J
PLoS One; 2009 Sep; 4(9):e7099. PubMed ID: 19787053
[TBL] [Abstract][Full Text] [Related]
10. A role for the ubiquitin ligase Nedd4 in membrane sorting of LAPTM4 proteins.
Milkereit R; Rotin D
PLoS One; 2011; 6(11):e27478. PubMed ID: 22096579
[TBL] [Abstract][Full Text] [Related]
11. Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.
Zhao L; Wang S; Xu M; He Y; Zhang X; Xiong Y; Sun H; Ding H; Geng W; Shang H; Liang G
Nat Commun; 2021 Jun; 12(1):3691. PubMed ID: 34140527
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of LAPTM5 in human cancer cells.
Nuylan M; Kawano T; Inazawa J; Inoue J
Oncotarget; 2016 May; 7(19):28320-8. PubMed ID: 27058622
[TBL] [Abstract][Full Text] [Related]
13. FGFR3 induces degradation of BMP type I receptor to regulate skeletal development.
Qi H; Jin M; Duan Y; Du X; Zhang Y; Ren F; Wang Y; Tian Q; Wang X; Wang Q; Zhu Y; Xie Y; Liu C; Cao X; Mishina Y; Chen D; Deng CX; Chang Z; Chen L
Biochim Biophys Acta; 2014 Jul; 1843(7):1237-47. PubMed ID: 24657641
[TBL] [Abstract][Full Text] [Related]
14. Spine‑specific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptor‑positive breast cancer by activating glutamine‑dependent mTOR signaling.
Meng Q; Zhou L; Liang H; Hu A; Zhou H; Zhou J; Zhou X; Lin H; Li X; Jiang L; Dong J
Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35294039
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal-associated transmembrane protein 5 (LAPTM5) is a molecular partner of CD1e.
Angénieux C; Waharte F; Gidon A; Signorino-Gelo F; Wurtz V; Hojeij R; Proamer F; Gachet C; Van Dorsselaer A; Hanau D; Salamero J; de la Salle H
PLoS One; 2012; 7(8):e42634. PubMed ID: 22880058
[TBL] [Abstract][Full Text] [Related]
16. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.
Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.
Liu Y; Zhang RX; Yuan W; Chen HQ; Tian DD; Li H; Jiang X; Deng ZL; Wang Y
Cell Physiol Biochem; 2018; 45(5):1759-1771. PubMed ID: 29495003
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
Chen L; Wang G; Luo Y; Wang Y; Xie C; Jiang W; Xiao Y; Qian G; Wang X
Int J Oncol; 2017 Jan; 50(1):263-271. PubMed ID: 27922670
[TBL] [Abstract][Full Text] [Related]
19. Ectopic overexpression of LAPTM5 results in lysosomal targeting and induces Mcl-1 down-regulation, Bak activation, and mitochondria-dependent apoptosis in human HeLa cells.
Jun DY; Kim H; Jang WY; Lee JY; Fukui K; Kim YH
PLoS One; 2017; 12(5):e0176544. PubMed ID: 28464033
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Lysosomal Degradation of Rab22a-NeoF1 Fusion Protein for Osteosarcoma Lung Metastasis.
Zeng C; Zhong L; Liu W; Zhang Y; Yu X; Wang X; Zhang R; Kang T; Liao D
Adv Sci (Weinh); 2023 Feb; 10(5):e2205483. PubMed ID: 36529692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
